EU medicines watchdog starts review of Merck COVID pill
The European Medicines Agency (EMA) – the European Union’s top medicines watchdog – has started a review of a potentially ground-breaking antiviral pill to treat COVID-19. The agency announced on Monday that it has launched a “rolling review” of molnupiravir, which was developed by United States pharmaceutical company Merck.
View the full story here: https://www.aljazeera.com/news/2021/10/25/eu-medicines-watchdog-starts-review-of-merck-covid-19-pill